Replies to post #22601 on Regen BioPharma Inc (RGBP)

[mrMando]

Agreed. Easy connect the dots type of 8k.

[lab40]

Nice to see you come to the other side "Luke"!! The force is strong with this one!! (RGBP)

[SidVicious]

As huge as the RGBP will fly like Kalobio dots?

[LoveAndLight]

Thank you 1~Eye! Agreed it is so obvious! Funding through this joint venture research collaboration between National Institutes of Health (NIH) and Regen BioPharma will BE obviously exclusively supported by NIH backed money. All Regen has to supply is the NR2F6 orphan nuclear receptor and their good research consultant DR. Harry Lander. The research will BE conducted in-house at the NCATS laboratories, which are completely funded by NIH.
It's all in the 8-K...

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11065814

Regen and NCATS shall collaborate to screen for small molecule compounds that activate or inhibit the orphan nuclear receptor, NR2F6 (“Research Project”).

NR2F6 orphan nuclear receptor cell lines will be provided by Regen.

NPC and LOPAC compound libraries will be used to screen this receptor at NCATS.

Project Abstract: These studies are designed to screen for small molecule compounds that activate or inhibit the orphan nuclear receptor, NR2F6. Small molecule compounds from the NCATs compound libraries will be screened against cell lines expressing either the ligand binding domain or the full length protein of NR2F6 fused to a luciferase-based reporter construct and stably expressed in HEK293 cells.

Blessings and best wishes,
LoveAndLight :-)